Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Filings indexed 1,264 across all filing types
Latest filing 2016-12-15 Regulatory Filings
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2016
Regulatory Filings
2016-12-15 English
Regulatory Filings 2016
Regulatory Filings
2016-12-15 English
Regulatory Filings 2016
Regulatory Filings
2016-12-15 English
Regulatory Filings 2016
Regulatory Filings
2016-12-15 English
Regulatory Filings 2016
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes an announcement of a material definitive agreement (a follow-on contract with the CDC), a press release about the contract and financial guidance, and forward-looking statements. There are no detailed financial statements or comprehensive financial analysis typical of an earnings release or annual/interim report. The document is not a transcript, proxy, or governance report. It is a regulatory filing announcing a material contract and related press release, consistent with the purpose of an 8-K. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (8428 characters) and content confirm it is not merely a brief announcement but a full 8-K filing, still fitting under RNS as per the definitions provided.
2016-12-08 English
Regulatory Filings 2016
Regulatory Filings
2016-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.